tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Pfizer (PFE)
NYSE:PFE
US Market
PFE
Pfizer
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Pfizer (PFE) Stock News & Sentiment

Compare
34,491 Followers
Pfizer’s Abrocitinib Study: A Potential Game-Changer for Atopic Dermatitis Treatment
Premium
Company Announcements
Pfizer’s Abrocitinib Study: A Potential Game-Changer for Atopic Dermatitis Treatment
4h ago
PFE
Pfizer and Astellas Pharma’s Prostate Cancer Study: A Potential Game-Changer?
Premium
Company Announcements
Pfizer and Astellas Pharma’s Prostate Cancer Study: A Potential Game-Changer?
4h ago
PFE
Pfizer’s New Study on Inotuzumab Ozogamicin: A Potential Game-Changer in Pediatric Leukemia Treatment
Premium
Company Announcements
Pfizer’s New Study on Inotuzumab Ozogamicin: A Potential Game-Changer in Pediatric Leukemia Treatment
4h ago
PFE
Pfizer’s MagnetisMM-4 Study: A New Hope for Multiple Myeloma Treatment
Premium
Company Announcements
Pfizer’s MagnetisMM-4 Study: A New Hope for Multiple Myeloma Treatment
4h ago
PFE
Pfizer’s Gene Therapy Study for Duchenne Muscular Dystrophy: Key Insights for Investors
Premium
Company Announcements
Pfizer’s Gene Therapy Study for Duchenne Muscular Dystrophy: Key Insights for Investors
4h ago
PFE
Pfizer’s New Study on Zavicefta: A Potential Game-Changer for Sepsis and Renal Impairment
Premium
Company Announcements
Pfizer’s New Study on Zavicefta: A Potential Game-Changer for Sepsis and Renal Impairment
1d ago
PFE
Pfizer’s Gene Therapy Study for Duchenne Muscular Dystrophy: Key Update for Investors
Premium
Company Announcements
Pfizer’s Gene Therapy Study for Duchenne Muscular Dystrophy: Key Update for Investors
1d ago
PFE
More PFE News >

PFE News on the Web

SMMT Q2 Loss Wider Than Expected, Ivonescimab Studies in Focus
Zacks
Neutral
The Zacks Analyst Blog Highlights Pfizer, Novo Nordisk and Eli Lilly
Zacks
Neutral
If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today
The Motley Fool
Neutral
Should Pfizer Stock Be in Your Portfolio After Solid Q2 Results?
Zacks
Neutral
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks
Neutral
2 Beaten-Down Stocks to Buy and Hold
The Motley Fool
Neutral
Trump Considers Cannabis Reclassification That Could Boost $45 Billion U.S. Market
TipRanks News
Neutral
Meet the 7.3% Yield Dividend Stock That Could Soar in 2026
The Motley Fool
Neutral

News Score - Last 7 Days

Neutral
PFE
Sector Average
Media Buzz
This Week19 articles
Weekly Average22 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PFE’s Media Buzz Sentiment?
19 articles about PFE were published this week. In an average week, 22 articles are published.
    What is PFE’s weekly average amount of articles?
    In an average week, 22 articles about PFE are published.
      What is PFE’s News Sentiment?
      50% of articles about PFE were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        RIGLRigel
        FARNFaron Pharmaceuticals Oy
        CRMDCormedix
        BLFSBioLife Solutions
        IMCRImmunocore Holdings
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing